Interferon and thymosin combination therapy in naive patients with chronic hepatitis C: Preliminary results

Liver

Volumn 18, Issue 5, 1998, Pages 366-369

  Moscarella, S ^a,b   Buzzelli, G ^a   Romanelli, R G ^a   Monti, M ^a   Giannini, C ^a   Careccia, G ^a   Marrocchi, E M ^a   Zignego, A L ^a  

^a UNIVERSITY OF FLORENCE   (Italy)

^b Dipartimento di Medicina Interna   (Italy)

Author keywords

Chronic hepatitis; HCV; Interferon alpha; Thymosin 1

Indexed keywords

ALANINE AMINOTRANSFERASE; ALPHA2B INTERFERON; THYMOSIN ALPHA1;

ADULT; ARTICLE; BIOCHEMISTRY; CLINICAL ARTICLE; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; FOLLOW UP; HEPATITIS C; HUMAN; MALE; RANDOMIZED CONTROLLED TRIAL; VIROLOGY;

EID: 0031752774     PISSN: 01069543     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-0676.1998.tb00819.x     Document Type: Article

References (22)

1. MARCELLIN P, BOYER N, GIOSTRA E, et al. Recombinant human alpha-interferon in patients with chronic non-A, non-B hepatitis: a multicenter randomized controlled trial from France. Hepatology 1991; 13: 393-7.
2. TINE F, MAGRIN S, CRAXI A, PAGLIARO L. Interferon for non-A, non-B chronic hepatitis. A meta-analysis of randomized clinical trials. J Hepatol 1991; 13: 192-9.
3. SHINDO M, DI BISCEGLIE A M, HOOFNAGLE J H. Long-term follow-up of patients with chronic hepatitis C treated with alpha-interferon. Hepatology 1992; 15: 1013-6.
4. CARITHERS JR R L, EMERSON S S. Therapy of hepatitis C: meta-analysis of interferon alfa-2b trials. Hepatology 1997; 26: 83S-88S.
5. ZIGNEGO A L, FONTANA R, PULITI S, et al. Relevance of inapparent coinfection by hepatitis B virus in alpha interferon-treated patients with hepatitis C virus chronic hepatitis. J Med Virol 1997; 51: 313-8.
6. KOZIEL M J, DUDLEY D, WONG J T, et al. Intrahepatic cytotoxic T lymphocytes specific for hepatitis C virus in persons with chronic hepatitis. J Immunol 1992; 149: 3339-44.
7. Low T L K, GOLDSTEIN A L. Thymosins: structure, function and therapeutic applications. Thymus 1984; 6: 27-42.
8. SERRATE S A, SCHULOF R S, LEONDARIDIS L, GOLDSTEIN A L, SZTEIN M B. Modulation of human natural killer cytotoxic activity, lymphokine production, and interleukin 2 receptor expression by thymic hormones. J Immunol 1987; 139: 2338-43.
9. REZAKOVIC I, ZAVAGLIA C, BOTTELLI R, IDEO G. A pilot study of thymosin alpha 1 therapy in chronic active hepatitis C. Hepatology 1993; 18: 252A.
10. RASI G, DI VIRGILIO D, MUTCHNICK M G, et al. Combination thymosin alpha I and lymphoblastoid interferon treatment in chronic hepatitis C. Gut 1996; 39: 679-83.
11. SHERMAN K E, SJOGREN M H, CREAGER R L, et al. Thymosin alpha-1 + interferon combination therapy for chronic hepatitis C: results of a randomized controlled trial. Hepatology 1996; 24: 402A.
12. ZIGNEGO A L, FERRI C, GIANNINT C, et al. Hepatitis C virus genotype analysis in patients with type II mixed cryoglobulinemia. Ann Int Med 1996; 124: 31-4.
13. OKAMOTO H, SUGIYAMA Y, OKADA S, et al. Typing hepatitis C virus by polymerase chain reaction with type-specific primers: applications to clinical surveys and tracing infectious sources. J Gen Virol 1992, 73: 673-9.
14. GIANNINI C, THIERS V, NOUSBAUM J B, STUYVER L, MAERTENS G, BRECHOT C. Comparative analysis of two assays for genotyping hepatitis C virus based on genotype-specific primers or probes. J Hepatol 1995; 23: 246-53.
15. KNODELL R G, ISHAK K G, BLACK W C, et al. Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis. Hepatology 1981; 1: 431-5.
16. LINDSAY K L. Therapy of hepatitis C: overview. Hepatology 1997; 26 (suppl. 1): 71S-77S.
17. ZAV'YALOW V P, DENESYUKM A I, ZAV'YALOVAM G A. Theoretical analysis of conformation and active sites of interferons. Immunol Lett 1989; 22: 173-81.
18. ANDREONE P, CURSARO C, GRAMENZI A, et al. A randomized controlled trial of thymosin-alpha 1 versus interferon alfa treatment in patients with hepatitis B, e antigen antibody and hepatitis B virus DNA-positive chronic hepatitis B. Hepatology 1996; 24: 774-7.
19. KOBAYASHI M, TANAKA E, SODEYAMA T, URUSHIHARA A, MATSUMOTO A, KIYOSAVVA K. The natural course of chronic hepatitis C: a comparison between patients with genotypes 1 and 2 hepatitis C viruses. Hepatology 1996; 23: 695-9.
20. POZZATO G, KANEKO S, MORETTI M, et al. Different genotypes of hepatitis C virus are associated with different severity of chronic liver disease. J Med Virol 1994; 43: 291-6.
21. KANAI K, KAKO M, OKAMOTO H. HCV genotypes in chronic hepatitis C and response to interferon. Lancet 1992, 339: 1543.
22. MITA E, HAYASHI N, HAGIWARA H, et al. Predicting interferon therapy efficacy from hepatitis C virus genotype and RNA titer. Dig Dis Sci 1994; 39: 977-82.